[307 Pages Report] In 2022, the global clinical chemistry analyzers market is likely to hold a value of US$ 13.6 Billion. With a CAGR of 4.8%, the market is projected at US$ 21.7 Billion during the forecast period from 2022 to 2032. Expansion of the market can be attributed to the rising geriatric population and the growing prevalence of chronic diseases.
“Increasing prevalence of chronic illness and rising adoption of the sedentary lifestyle are expected to play the most vital role in driving the market growth in the forecast period. Besides, growing awareness about point-to-care testing can also boost the market expansion in the forthcoming time. “
Attributes | Details |
---|---|
Global Clinical Chemistry Analyzers Market CAGR (2022 to 2032) | 4.8% |
Global Clinical Chemistry Analyzers Market Size (2022) | US$ 13.6 Billion |
Global Clinical Chemistry Analyzers Market Size (2032) | US$ 21.7 Billion |
Basic metabolic panel (BMP) is anticipated to secure a larger market share during the forecast period. The benefits offered by these tests have resulted in an increased demand for the same, thus, augmenting the segmental growth in the forecast period. Also, BMP is gaining significant demand for purposes such as; newborn screening, which allows early detection of congenital genetic and metabolic disorders.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The rising geriatric population in developing countries and the aging baby boomers are expected to benefit the market in the forecast period. With advancing age, there has been a significant rise in the prevalence of diseases such as; cardiovascular, diabetes, hypertension, kidney diseases, and liver. Increased cases of chronic illness are expected to generate significant demand for tests prescribed for the diagnosis, prevention, and treatment of the same.
As per the United States Census Bureau’s Statistics, between 2020 and 2030, the number of the elderly population is expected to increase by 18 million. The number of people aged above 85 years and older is likely to triple from an estimated 6 million to about 20 million by 2060. Such a significant rise in the geriatric population will augment the market size in the forecast period.
Additionally, the introduction of an advanced chemistry analyzer is expected to offer various benefits to the market in the forecast period. For instance, in July 2019, Trivitron Healthcare, announced the ‘Nanolab 200’. It is a completely automated chemistry analyzer.
The product is integrated with cutting-edge liquid level detection technology and is expected to enhance efficiency in clinical laboratories. Such initiatives are expected to propel the market in the forecast period.
The ongoing development in clinical chemistry analyzers is expected to offer various remunerative opportunities for market growth in the forecast period. In May 2022, Transasia unveiled a range of IVD solutions with a better customer experience at the Medical Fair 2022.
The Erba XL 640 is a fully automated random access clinical chemistry analyzer with the autoloader. The equipment helps in establishing better workflow and reduces the manual work of staff members and helps in achieving faster TAT.
Moreover, implementation of favorable government initiatives, schemes, and funding that offer support to the development of labs and diagnostics are expected to give remunerative opportunities to the industry in the assessment period. Owing to the aforementioned factors, the market is expected to witness various opportunities for expansion in the forecast period, which will expand the market size during the forecast period.
The demand for high capital investments is expected to play a significant role in limiting the market growth during the forecast period. Advanced and high-volume clinical chemistry analyzers can be afforded by large and established hospitals.
Small labs, independent practitioners, and physician’s offices do not have sufficient budgets and are not able to avail of its benefits, thereby, hampering the market growth. Also, the high-fixed cost associated is projected to further inhibit the market expansion in the assessment period.
Also, with a lack of lab technicians and a scarcity of expertise, the industry is likely to suffer. The prior-mentioned dearth can be attributed to the growing patient base and the rising number of cash-strapped colleges closing their clinical lab programs.
Therefore, the gap created between the supply and demand of pathologists and lab technicians worldwide can add to the hindrance of market expansion during the forecast time.
However, ongoing technical development and surging cases of chronic illnesses amongst the geriatric population are projected to offer significant opportunities for expansion in the assessment period and also act as a potential counter to the impeding causes and propel the market development.
Global Clinical Chemistry Analyzers Market:
Attributes | Global Clinical Chemistry Analyzers Market |
---|---|
CAGR (2022 to 2032) | 4.8% |
Market Value (2032) | US$ 21.7 Billion |
Growth Factor | The rapid rise in the geriatric population and increasing incidences of chronic illness across the globe are expected to boost the market in the forecast period. |
Opportunities | Ongoing development in the clinical chemistry analyzers and implementation of favorable government schemes are anticipated to offer opportunities for expansion in the forecast period. |
Global Chronic Diseases Management Market:
Attributes | Global Chronic Diseases Management Market |
---|---|
CAGR (2022 to 2032) | 12.98% |
Market Value (2032) | US$ 21 Billion |
Growth Factor | Increasing cases of obesity and diabetes amongst the geriatric population are expected to boost the market growth in the forecast period. |
Opportunities | Advancements in digital healthcare services and development in IT healthcare services are expected to offer significant opportunities for market expansion in the forecast period. |
Global Geriatric Care Services Market:
Attributes | Global Geriatric Care Services Market |
---|---|
CAGR (2022 to 2032) | 6% |
Market Value (2032) | US$ 8 Billion |
Growth Factor | Availability of expertise, professional education, and transparency regarding the quality of care and remote patient management are anticipated to expand the market growth in the forecast period. |
Opportunities | Ongoing technological development in the sector is expected to offer significant opportunities for expansion in the coming time |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
As per the analysis, the global chemistry analyzers market, by product, is expected to be dominated by reagents. The segment is likely to expand at a CAGR of 4.6% in the assessment period from 2022-to 2032. Expansion of the market can be attributed to their economical nature and also because they offer minimum deviation in performance.
On the other hand, based on the test, the Basic Metabolic Panel segment is anticipated to secure the largest market share during the forecast period. The segment is predicted to expand at a CAGR of 4.3% in the assessment period.
The growth of the market can be attributed to the increasing incidence of diabetes and other chronic diseases. Also, the adoption of preventive healthcare is another salient factor developing the segmental growth in the forecast period.
As per the analysis, North America is expected to dominate the market in the forecast period. In the region, the U.S is expected to dominate the market. The region is projected to garner US$ 7.5 Billion while expanding at a CAGR of 4.3% in the assessment time.
The growth of the market can be attributed to the increasing healthcare expenditure and the rising popularity of point-of-care testing. Moreover, increasing product launches are expected to benefit the regional market in the forecast period.
APAC is anticipated to record the highest CAGR in the forecast period. Among all, China is expected to lead the regional market. The country is expected to garner US$ 1.5 Billion by 2032. Japan and South Korea are anticipated at US$ 1.2 Billion and US$ 876.1 Million, respectively.
Expansion of the market can be attributed to the presence of developing countries. Also, the development of healthcare infrastructure is expected to benefit the market.
Moreover, rapid urbanization in the region has resulted in the adoption of a sedentary lifestyle, thereby, benefitting the industry in the forecast period. In addition, the launch of innovative products in the region is another salient factor augmenting the market size.
For instance, in May 2022, Snibe, a China-based player, launched the new Biossays C8 automatic biochemistry analyzer. It marks the beginning of a new journey in clinical chemistry management. It allows powerful performance and modular scalability allows labs to realize fill automation and maximum efficiency.
Europe is expected to experience decent growth during the forecast period. The region is likely to be dominated by the U.K. The U.K is likely to garner a market value of US$ 933.6 Million by 2032. The growth of the market can be attributed to the increasing geriatric population across the region.
Country | Estimated CAGR |
---|---|
USA | 4.3% |
UK | 3.7% |
China | 4% |
Japan | 4% |
South Korea | 3.9% |
Key players in the global clinical chemistry analyzers market include Thermo Fisher Scientific, Inc., F.Hoffmann La Roche, Johnson & Johnson, Danaher Corporation, and Siemens AG.
Recent updates from the industry are:
The global clinical chemistry analyzers market in 2022 is expected to secure US$ 13.6 Billion in 2022.
The global clinical chemistry analyzers market is predicted to garner US$ 21.7 Billion by 2032.
According to FMI, clinical chemistry analyzers demand in the U.S is likely to secure a market value of US$ 7.5 Billion by 2032.
Clinical chemistry reagents is expected dominate, registering a CAGR of 4.6% by 2032
China is expected to exhibit a CAGR of 4% from 2022-2032 with respect to clinical chemistry analyzers sales
South Korea to hold a market value of US$ 876.1 Million by 2032
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Mn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Mn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032 6.1. Historical Market Analysis, 2015-2021 6.2. Current and Future Market Projections, 2022-2032 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2021 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2032 8.3.1. Analyzers 8.3.1.1. Small 8.3.1.2. Medium 8.3.1.3. Large 8.3.1.4. Very Large 8.3.2. Reagents 8.3.2.1. Calibrators 8.3.2.2. Controls 8.3.2.3. Standards 8.3.2.4. Others 8.3.3. Others 8.4. Market Attractiveness Analysis By Product 9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Test 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Analysis By Test, 2015-2021 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test, 2022-2032 9.3.1. Basic Metabolic Panel 9.3.2. Electrolyte Panel 9.3.3. Liver Panel 9.3.4. Lipid Profile 9.3.5. Renal Profile 9.3.6. Thyroid Function Panel 9.3.7. Specialty Chemical Tests 9.4. Market Attractiveness Analysis By Test 10. Global Market Analysis 2015-2021 and Forecast 2022-2032, By End-use 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By End-use, 2015-2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2022-2032 10.3.1. Hospitals 10.3.2. Academic Research Centers 10.3.3. Diagnostic Laboratories 10.3.4. Others 10.4. Market Attractiveness Analysis By End-use 11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021 11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2015-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 12.4.1. By Country 12.4.1.1. U.S. 12.4.1.2. Canada 12.4.1.3. Rest of North America 12.4.2. By Product 12.4.3. By End-use 12.4.4. By Test 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Product 12.5.3. By End-use 12.5.4. By Test 13. Latin America Market Analysis 2015-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Product 13.4.3. By End-use 13.4.4. By Test 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Product 13.5.3. By End-use 13.5.4. By Test 14. Europe Market Analysis 2015-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. U.K. 14.4.1.4. Italy 14.4.1.5. Benelux 14.4.1.6. Nordic Countries 14.4.1.7. Rest of Europe 14.4.2. By Product 14.4.3. By End-use 14.4.4. By Test 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Product 14.5.3. By End-use 14.5.4. By Test 15. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. Rest of Asia Pacific 15.4.2. By Product 15.4.3. By End-use 15.4.4. By Test 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Product 15.5.3. By End-use 15.5.4. By Test 16. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021 16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032 16.4.1. By Country 16.4.1.1. GCC Countries 16.4.1.2. South Africa 16.4.1.3. Turkey 16.4.1.4. Rest of Middle East and Africa 16.4.2. By Product 16.4.3. By End-use 16.4.4. By Test 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Product 16.5.3. By End-use 16.5.4. By Test 17. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.2.2.1. By Product 17.2.2.2. By End-use 17.2.2.3. By Test 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.3.2.1. By Product 17.3.2.2. By End-use 17.3.2.3. By Test 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.4.2.1. By Product 17.4.2.2. By End-use 17.4.2.3. By Test 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.5.2.1. By Product 17.5.2.2. By End-use 17.5.2.3. By Test 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.6.2.1. By Product 17.6.2.2. By End-use 17.6.2.3. By Test 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.7.2.1. By Product 17.7.2.2. By End-use 17.7.2.3. By Test 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.8.2.1. By Product 17.8.2.2. By End-use 17.8.2.3. By Test 17.9. BENELUX Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.9.2.1. By Product 17.9.2.2. By End-use 17.9.2.3. By Test 17.10. UK Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.10.2.1. By Product 17.10.2.2. By End-use 17.10.2.3. By Test 17.11. Nordic Countries Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.11.2.1. By Product 17.11.2.2. By End-use 17.11.2.3. By Test 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.12.2.1. By Product 17.12.2.2. By End-use 17.12.2.3. By Test 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.13.2.1. By Product 17.13.2.2. By End-use 17.13.2.3. By Test 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.14.2.1. By Product 17.14.2.2. By End-use 17.14.2.3. By Test 17.15. GCC Countries Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.15.2.1. By Product 17.15.2.2. By End-use 17.15.2.3. By Test 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.16.2.1. By Product 17.16.2.2. By End-use 17.16.2.3. By Test 17.17. Turkey Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2022-2032 17.17.2.1. By Product 17.17.2.2. By End-use 17.17.2.3. By Test 17.17.3. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional footprint of Players 18.4.2. Product footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. F.Hoffmann La Roche 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. Thermo Fisher Scientific, Inc. 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. Johnson & Johnson 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. Siemens AG 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. Danaher Corporation 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 19.3.6. Abbott Laboratories 19.3.6.1. Overview 19.3.6.2. Product Portfolio 19.3.6.3. Sales Footprint 19.3.6.4. Strategy Overview 19.3.7. HORIBA Ltd. 19.3.7.1. Overview 19.3.7.2. Product Portfolio 19.3.7.3. Sales Footprint 19.3.7.4. Strategy Overview 19.3.8. Sysmex Corporation 19.3.8.1. Overview 19.3.8.2. Product Portfolio 19.3.8.3. Sales Footprint 19.3.8.4. Strategy Overview 19.3.9. EKF Diagnostics 19.3.9.1. Overview 19.3.9.2. Product Portfolio 19.3.9.3. Sales Footprint 19.3.9.4. Strategy Overview 19.3.10. ELITech Group 19.3.10.1. Overview 19.3.10.2. Product Portfolio 19.3.10.3. Sales Footprint 19.3.10.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports